Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. - Wikidata - wikimedia - TriplyDB

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

http://www.wikidata.org/entity/Q39217323

about

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA ApoptomiRs of Breast Cancer: Basics to Clinics Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.MicroRNAome genome: a treasure for cancer diagnosis and therapy.Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines Clinical Diagnostic Implications of Body Fluid MiRNA in Oral Squamous Cell Carcinoma: A Meta-Analysis.Novel combination of serum microRNA for detecting breast cancer in the early stage.Circulating microRNA-based screening tool for breast cancer.A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.The Use of Redox Expression and Associated Molecular Damage to Evaluate the Inflammatory Response in Critically Ill Patient with Severe Burn.The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography.Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.Down-regulation of traditional oncomiRs in plasma of breast cancer patients.Lab-on-a-Chip Platforms for Detection of Cardiovascular Disease and Cancer Biomarkers.MicroRNA Expression in Laser Micro-dissected Breast Cancer Tissue Samples - a Pilot Study.Development of a predictive miRNA signature for breast cancer risk among high-risk women.Role of micro-RNAs in breast cancer surgery.MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.Candidate miRNAs in human breast cancer biomarkers: a systematic review.Meta-analysis of microRNA expression profiling studies in human cervical cancer.

P2860

Q26748881-3A880FF7-D83D-4ACF-A2FB-94A5AB6610A3 Q26796590-1C2832D5-9391-4301-A988-04D33AC2D071 Q27011221-4F173C2A-5350-4F03-8FDE-2299A84ED874 Q28072414-AD73F530-D6FA-4C0D-954F-293E9C12C0E8 Q33864278-E38F74E2-84FE-4DDE-B010-3049C20484B7 Q33917664-94A21677-2920-4515-818D-4D680323475B Q35094742-D83A37D4-3F94-428C-8625-A7CCEDC38AA5 Q35137273-D63A05DF-00FB-4628-A80D-C9D4F7FC10A9 Q35142413-7B617B1B-D52B-4BED-92ED-14A95FFBAD10 Q35632022-143CFB22-AC64-4DF4-BE33-9FE3C83E247A Q35704188-0A445C99-B8ED-47D1-90A5-C6D381DF6FAB Q35789307-455A4658-22FB-429B-B509-4D0C23CCCC81 Q35791145-E2F4D294-F935-4773-9EE6-7F8492EC4AE4 Q35835222-6A01CA57-F7B8-4382-A05C-57E9059CF40A Q35919291-C5011A30-40D5-462F-AAD6-0C61EDDAD6F4 Q36118327-BAC57BD6-C15E-4E04-BE21-BDCB462DBB07 Q36256059-6191BD95-0CEF-47AB-BE59-6800D1962F21 Q36746303-98856A40-4194-47FF-8F20-42DE4B77396C Q36905676-38B678AD-9A0E-40B4-AD84-7123864D7629 Q37641977-156E10C6-0B62-4826-84CD-5C37FE78BE3A Q38645381-3BE13B35-E42B-4254-89BF-ABFDD6B2D190 Q38855547-658A1528-A7D0-4B93-93D2-52BA37E94FAA Q38886081-91E276F2-4E4F-4CF3-A3B5-BB72EA11F276 Q38902431-7FC96A91-1A43-48A8-B401-5025F0B2B7EA Q38910561-85B1C63C-3249-41F1-94D0-687E6A288907 Q39097267-2157F5B8-84EF-4B9B-A6A0-5FEB9D22E47E Q40477629-DD4F0679-C042-4593-99E8-3EC5EEBAE5B8 Q40764983-C5AA7209-F395-439E-838D-955BB3BD4248 Q42122645-75244680-7529-45F2-9253-156A5DDAB92C Q46013493-4B661BFD-656E-45A5-9F35-EEDEE6331E19 Q47098442-584D441B-3B43-4032-8522-631EE79E1D6F Q47274844-A6B38182-B8EF-4E2C-A739-F3C859F09FC5 Q47696064-01DDDB7E-D1BA-4C8E-BA50-5F39E4DE6F6F Q47724615-16C0153F-D18E-4B6E-8316-D9BD2079D36C Q47728281-670FB61F-E3AD-4EAE-8A7D-A88B7EC651BA Q47994022-54862967-A429-4454-84E4-ED0F470692C9 Q48180449-4B398F0A-929E-40BC-B33F-4DFF01F86782 Q48234270-9EB88B8A-BAB0-4E27-AE38-F5685BAB603E Q50171133-5E33BEB6-8A43-489C-8674-BE1FCEF98D0C Q50983395-968DAE9B-B441-4E75-BC66-31DCA74E37BE

P2860

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

http://www.wikidata.org/entity/Q39217323

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Novel circulating microRNA sig ...... cancer: a case control study.

@en

Novel circulating microRNA sig ...... cancer: a case control study.

@nl

type

label

Novel circulating microRNA sig ...... cancer: a case control study.

@en

Novel circulating microRNA sig ...... cancer: a case control study.

@nl

prefLabel

Novel circulating microRNA sig ...... cancer: a case control study.

@en

Novel circulating microRNA sig ...... cancer: a case control study.

@nl

P1433

Q39217323-5B8C0C2C-84BB-441C-8DEA-62C013F3CA7E

P1476

Q39217323-63CD5D4E-EAF5-4ABB-85B8-52952DEBE485

P2093

Q39217323-439AB01F-9D01-4A44-892A-D7DBA30F920D

Q39217323-A08A491A-8A0B-4FC3-BEE7-249EED307ABE

Q39217323-E0FAFD63-9B70-49E7-8DE9-D8C820E5E927

Q39217323-F2089738-FC4A-4605-B4C3-8FFC2433039C

P2860

Q39217323-005849EE-4DBC-4932-A54C-9967BC1D7C59

Q39217323-04767F8E-AA4E-43EB-9DDD-51A22C3A9967

Q39217323-05FBE102-440F-4F63-979C-261ECD29DB48

Q39217323-0738080E-A80A-4D76-A671-5D536B88740C

Q39217323-0C341402-7183-4D7F-BB56-DDCE7E048A99

Q39217323-0FFDE417-4306-4CFA-9EE2-CEDB2F3AF6E7

Q39217323-124AC3A9-0C7E-4C75-834F-DDB33F549715

Q39217323-13A2B46A-E4AC-420D-817A-164DE2ED0D4A

Q39217323-1CE4D023-F006-4023-8549-162B03A2E0D9

Q39217323-1D97448E-6AFB-452C-BCFA-810D96DD8A71

P304

Q39217323-9033C84B-6101-4803-AE8C-6F1B33E11FC9

P31

Q39217323-A0866789-CB46-4AFE-BB64-323E1DC82F52

P356

Q39217323-94701988-BA12-4EAF-9BAA-D8F1811591C1

P433

Q39217323-9F895473-0C2A-463F-8467-6EEA617915A6

P478

Q39217323-5AB4988E-467E-47E8-AC72-3966E6007474

P50

Q39217323-2CBAB89C-3C7A-43CD-9CBD-24F5AFC0AC2D

Q39217323-8C8B4965-2B5B-45B8-851F-7C95C3C9F181

Q39217323-C1CD9517-A17D-46EC-A289-1766CE1BE28C

P577

Q39217323-072F51F4-4E25-424B-8004-13026B218A6F

P5875

Q39217323-B42281F4-F3D5-411B-A9E6-7EFC6134DA06

P698

Q39217323-BD4F00B7-690A-456A-8823-1B1E3C64F1A2

P921

Q39217323-6CBDBB7C-4784-4EAB-8580-06EF20AD29B8

P932

Q39217323-439C4B5B-6BEC-4696-AC7D-9E0C1CD6CC25

P356

J.MOLONC.2014.03.002

P1433

Molecular Oncology

P1476

Novel circulating microRNA sig ...... t cancer: a case control study

@en

P2093

Harald Binder

http://www.w3.org/2001/XMLSchema#string

Karina Gravgaard

http://www.w3.org/2001/XMLSchema#string

Maria B Lyng

http://www.w3.org/2001/XMLSchema#string

Søren Cold

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

Next-generation sequencing of microRNAs for breast cancer detection

MicroRNAs: control and loss of control in human physiology and disease

Circulating microRNAs as stable blood-based markers for cancer detection.

MicroRNA gene expression deregulation in human breast cancer

MicroRNA expression profiles classify human cancers

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

microRNAs as oncogenes and tumor suppressors

P304

874-883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLONC.2014.03.002

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Henrik J. Ditzel

Annette R Kodahl

P577

2014-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260838060

http://www.w3.org/2001/XMLSchema#string

P698

24694649

http://www.w3.org/2001/XMLSchema#string

P921

P932

5528529

http://www.w3.org/2001/XMLSchema#string